- Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals
-
Kim MH, Kim DK, Eun HS, Rou WS, Kim SH, Lee BS
- KMID: 2471149
- Korean J Gastroenterol.
- 2020 Feb;75(2):98-102.
- doi: 10.4166/kjg.2020.75.2.98
Hepatic hydrothorax is a transudative pleural effusion that complicates advanced liver cirrhosis. Patients refractory to medical treatment plus salt restriction and diuretics are considered to have refractory hepatic hydrothorax and... -
- CITED
-
- Close
- SHARE
-
- Close
- Kidney disease in patients with chronic liver disease
-
Chang JH
- KMID: 2467981
- J Korean Med Assoc.
- 2020 Jan;63(1):14-19.
- doi: 10.5124/jkma.2020.63.1.14
The kidneys are closely connected with several organs, including the liver, and can therefore be negatively affected when the liver is damaged. The most common cause of chronic liver disease... -
- CITED
-
- Close
- SHARE
-
- Close
- An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
-
Lee YJ, Heo J, Kim DY, Chung WJ, Tak WY, Kim YJ, Paik SW, Sim E, Kulasingam S, Talwani R, Haber B, Hwang P
- KMID: 2467250
- Clin Mol Hepatol.
- 2019 Dec;25(4):400-407.
- doi: 10.3350/cmh.2019.0006
BACKGROUND/AIMS: In the Republic of Korea, an estimated 231,000 individuals have chronic hepatitis C virus (HCV) infection. The aim of the present analysis was to evaluate the safety and efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and risk factors of dysphagia after variceal band ligation
-
Arasu S, Liaquat H, Suri J, Ehrlich AC, Friedenberg FK
- KMID: 2467247
- Clin Mol Hepatol.
- 2019 Dec;25(4):374-380.
- doi: 10.3350/cmh.2019.0019
BACKGROUND/AIMS: There is a lack of data on long-term morbidity, particularly dysphagia, following endoscopic variceal band ligation (EVL). The aim of this study are to assess the incidence of dysphagia... -
- CITED
-
- Close
- SHARE
-
- Close
- Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
-
Parigi TL, Torres MC, Aghemo A
- KMID: 2467245
- Clin Mol Hepatol.
- 2019 Dec;25(4):360-365.
- doi: 10.3350/cmh.2019.0022
Despite the high efficacy of direct acting antivirals (DAAs) not all patients successfully clear hepatitis C virus infection, in fact, approximately 1–3% fail to reach a sustained virological response 12... -
- CITED
-
- Close
- SHARE
-
- Close
- The Management Outcome and Expansion Strategy for Treatment of Hepatitis C Virus Infection among Persons Affected with Leprosy
-
Lee MW, Park HC
- KMID: 2466492
- Korean Lepr Bull.
- 2019 Dec;52(1):51-54.
- doi: 10.33161/klb.2019.52.1.51
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study
-
Shin SK, Lee JW, Ra H, Kwon OS, Shin JB, Jin YJ, Lee S, Han KJ, Kim YN, Kim TH, Kim YS, Kim JH
- KMID: 2460924
- J Korean Med Sci.
- 2019 Oct;34(41):e264.
- doi: 10.3346/jkms.2019.34.e264
BACKGROUND: The long-term data with direct acting antiviral agents were rare. This study investigated the durability of a sustained virologic response (SVR) and the improvement of fibrosis after daclatasvir and... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Onset Polymorphic Post-transplant Lymphoproliferative Disease Mimicking a Solitary Necrotizing Abscess in a Graft Liver
-
Sung PS, Lee J, Lee J, Nam HC, Bae SH, Yoon SK
- KMID: 2463619
- J Liver Cancer.
- 2019 Sep;19(2):165-170.
- doi: 10.17998/jlc.19.2.165
Although post-transplantation lymphoproliferative disease (PTLD) after liver transplantation is very rare, its prognosis is worse than that of PTLD following other types of solid organ transplantation. Here, we report a... -
- CITED
-
- Close
- SHARE
-
- Close
- Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
-
Hassan EA, Rehim AS, Abdel-Malek MO, Ahmed AO, Abbas NM
- KMID: 2459793
- Clin Mol Hepatol.
- 2019 Sep;25(3):317-325.
- doi: 10.3350/cmh.2018.0097
BACKGROUND/AIMS: Cellulitis is a common infection in patients with liver cirrhosis. We aimed to compare risk factors, microbial aspects, and outcomes of cellulitis in compensated and decompensated hepatitis C virus... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
-
Na SK, Song BC
- KMID: 2459785
- Clin Mol Hepatol.
- 2019 Sep;25(3):234-244.
- doi: 10.3350/cmh.2018.0108
Hepatitis C virus (HCV) infection is a major risk factor for liver cirrhosis and hepatocellular carcinoma (HCC), and is a leading cause of liver-related deaths worldwide. Recently available direct-acting antiviral... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea
-
Ahn YH, Park H, Lee MJ, Kim DH, Cho SB, Cho E, Jun CH, Choi SK
- KMID: 2458512
- Gut Liver.
- 2019 Sep;13(5):549-556.
- doi: 10.5009/gnl18432
BACKGROUND/AIMS: Patients with Hansen’s disease are the most vulnerable to hepatitis C. However, no data on the treatment efficacy of direct-acting antiviral agents (DAAs) are available in this group. Therefore,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction and Staging of Hepatic Fibrosis in Children with Hepatitis C Virus: A Machine Learning Approach
-
Barakat NH, Barakat SH, Ahmed N
- KMID: 2457469
- Healthc Inform Res.
- 2019 Jul;25(3):173-181.
- doi: 10.4258/hir.2019.25.3.173
OBJECTIVES: The aim of this study is to develop an intelligent diagnostic system utilizing machine learning for data cleansing, then build an intelligent model and obtain new cutoff values for... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
-
Sato S, Moriya K, Furukawa M, Saikawa S, Namisaki T, Kitade M, Kawaratani H, Kaji K, Takaya H, Shimozato , Sawada Y, Seki K, Kitagawa K, Akahane T, Mitoro A, Okura Y, Yamao J, Yoshiji H
- KMID: 2447252
- Clin Mol Hepatol.
- 2019 Mar;25(1):65-73.
- doi: 10.3350/cmh.2018.0070
BACKGROUND/AIMS: L-carnitine not only alleviates hyperammonemia and reduces muscle cramps in patients with liver cirrhosis, but also improves anemia in patients with chronic hepatitis and renal dysfunction. This study prospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
-
Mölleken , Ahrens M, Schlosser , Dietz J, Eisenacher M, Meyer HE, Schmiegel , Holmskov U, Sarrazin C, Sorensen G, Sitek B, Bracht T
- KMID: 2447250
- Clin Mol Hepatol.
- 2019 Mar;25(1):42-51.
- doi: 10.3350/cmh.2018.0029
BACKGROUND/AIMS: An estimated 80 million people worldwide are infected with viremic hepatitis C virus (HCV). Even after eradication of HCV with direct acting antivirals (DAAs), hepatic fibrosis remains a risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
-
Marascio N, Quirino A, Barreca GS, Galati L, Costa C, Pisani V, Mazzitelli M, Matera G, Liberto MC, Focà A, Torti C
- KMID: 2447247
- Clin Mol Hepatol.
- 2019 Mar;25(1):30-36.
- doi: 10.3350/cmh.2018.0061
Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major health problem. Since 2011, anti-HCV therapy with availability of direct-acting antiviral drugs... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on Hemodialysis
-
Lee BS, Song MJ, Kwon JH, Lee TH, Jang JW, Kim SH, Lee SH, Kim HS, Kim JH, Kim SB, Ko SY, Song DS
- KMID: 2446804
- Gut Liver.
- 2019 Mar;13(2):191-196.
- doi: 10.5009/gnl18240
BACKGROUND/AIMS: We evaluated the efficacy and safety of daclatasvir (DCV) and asunaprevir (ASV) in patients with chronic hepatitis C virus (HCV) infection on hemodialysis. METHODS: We performed a single-arm, multicenter prospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Apolipoprotein E Genotype and Expression Correlated with Hepatitis C Virus Genotype and Infection
-
Park GN, Jo HJ, Kim HR, Kim MJ, Shin KA, Hong SB, Chang KS
- KMID: 2442585
- J Bacteriol Virol.
- 2019 Mar;49(1):27-38.
- doi: 10.4167/jbv.2019.49.1.27
The hepatitis C virus (HCV) is a globally prevalent human pathogen that causes persistent liver infections in most infected individuals. Several studies reported that HCV particles are enriched in apolipoprotein... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
-
Ko SY, Choe WH
- KMID: 2433297
- Clin Mol Hepatol.
- 2018 Dec;24(4):351-357.
- doi: 10.3350/cmh.2017.0063
The advent of novel, direct-acting antiviral (DAA) regimens for hepatitis C virus (HCV) infection has revolutionized its treatment by producing a sustained virologic response of more than 95% with few... -
- CITED
-
- Close
- SHARE
-
- Close
- Seropositivity of Hepatitis C Virus among Persons affected Leprosy in Korea
-
Kim JP, Kang KH, Park JM
- KMID: 2429659
- Korean Lepr Bull.
- 2018 Dec;51(1):13-21.
- doi: 10.33161/klb.2018.51.1.13
BACKGROUND: Leprosy is a contagious chronic granulomatous disease and is a disease that is associated with defects in cellular immunity. A high prevalence of hepatitis C virus infection in leprosy... -
- CITED
-
- Close
- SHARE
-
- Close
- Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5
-
Gong W, Guo X, Zhang Y
- KMID: 2426332
- Yonsei Med J.
- 2018 Dec;59(10):1181-1189.
- doi: 10.3349/ymj.2018.59.10.1181
PURPOSE: Hepatitis C virus (HCV) poses a risk of chronic liver disease and threatens a significant number of people worldwide. MicroRNAs (miRNAs) are linked to the regulation of hepatocarcinogenesis. Although... -
- CITED
-
- Close
- SHARE
-
- Close
